Qualifying manufacturers will be able to submit some data while clinical trials are ongoing. Marty Makary is the commissioner ...

Learn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.

The injectable HIV prevention treatment Yetzugo, made by Gilead Sciences, has received FDA approval, offering a twice-yearly ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

But the Trump administration’s cuts to HIV programs in the U.S. and abroad could undermine the drug’s rollout.

Gilead has plans for a rapid launch in the United States as well as a wider rollout of the drug in collaboration with global ...

THE United States Food and Drug Administration (FDA) on Wednesday approved Gilead Sciences' lenacapavir, a drug to be injected twice annually, for preventing HIV infection in adults and adolescents at ...

The U.S. Food and Drug Administration announced Thursday it halted all new clinical trials that entail sending Americans’ ...

The US FDA has approved lenacapvir, sold under the brand name Yeztugo, as the first preventive treatment against HIV. It is a ...

The Food and Drug Administration (FDA) has approved the HIV preventing drug, lenacapavir, which only has to be administered twice a year. The injectable drug, sold as Yeztugo, can be taken by those at ...

The US Food and Drug Administration (FDA) has approved a drug that prevents HIV. It is called Yeztugo, although it is also known as lenacapavir, developed by Gilead Sciences It is ...

The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection ...